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Abstract
Next-generation sequencing (NGS) technologies are providing genomic information for an
increasing number of healthy individuals and patient populations. In the context of the large
amount of generated genomic data that is being generated, understanding the effect of dis-
ease-related mutations at molecular level can contribute to close the gap between genotype
and phenotype and thus improve prevention, diagnosis or treatment of a pathological condi-
tion. In order to fully characterize the effect of a pathological mutation and have useful infor-
mation for prediction purposes, it is important first to identify whether the mutation is located
at a protein-binding interface, and second to understand the effect on the binding affinity of
the affected interaction/s. Computational methods, such as protein docking are currently
used to complement experimental efforts and could help to build the human structural inter-
actome. Here we have extended the original pyDockNIP method to predict the location of
disease-associated nsSNPs at protein-protein interfaces, when there is no available struc-
ture for the protein-protein complex. We have applied this approach to the pathological inter-
action networks of six diseases with low structural data on PPIs. This approach can almost
double the number of nsSNPs that can be characterized and identify edgetic effects in many
nsSNPs that were previously unknown. This can help to annotate and interpret genomic
data from large-scale population studies, and to achieve a better understanding of disease
at molecular level.
Introduction
Next-generation sequencing (NGS) technologies have dramatically lowered gene sequencing
costs, and are providing genomic information for an increasing number of healthy individuals
and patient populations. To make the most of all these increasingly available genomic data, we
need to understand better the link between the genetic information and the phenotype it pro-
duces [1]. In this context, the identification and characterization of genetic variants that can be
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associated to a given disease is the first step in the pursuit of personalized medicine.
Approaches like genomic-wide association studies (GWAS) are generating large datasets of
genetic variants associated with disorders, which are being deposited in public databases, such
as Online Mendelian Inheritance in Man (OMIM) [2], and the database of Genotypes and
Phenotypes (dbGaP) [3].
Among the different possible genetic variants found in human populations, non-synony-
mous single nucleotide polymorphisms (nsSNPs) are small changes in the DNA of an individ-
ual that result in a single aminoacid mutation at protein level. Understanding the effect of
disease-related mutations at molecular level can contribute to close the gap between genotype
and phenotype and thus improve prevention, diagnosis or treatment of a pathological condi-
tion. In a first approach, the impact of a mutation in the functional activity of a protein (e.g. an
enzyme) can be described in structural terms, because it produces a change in protein folding
and stability [4] or it affects a known active or allosteric site. Many structural and biophysical
studies have analyzed the effect of a mutation in protein stability, and this effect can be esti-
mated based on computational modeling and calculations [5]. However, in the majority of the
cases, proteins are not acting alone, but are forming specific interactions with other biomole-
cules and are thus part of intricate interaction networks (metabolic pathways, functional com-
plexes, signaling networks, etc.). Large-scale studies at proteomic level have become widely
accessible to the community [6–8] and are generating a diverse and increasing amount of data,
including protein binding and pathway information [9–11]. This has allowed the computa-
tional construction of genome-wide networks, or "interactomes" [12], in which the biological
system can be ideally described as a PPI network, where the nodes are proteins and the edges
represent interactions between proteins [13].
In this scenario, it will be important to consider the impact of a given mutation in such net-
works. By gaining a system-wide perspective of protein functions, we can further study which
subsets of PPIs are essential in regulating a particular biological process and how genetic vari-
ants such as non-synonymous single nucleotide polymorphisms (nsSNPs) affect these PPIs
[13,14]. For instance, if a mutation affects the folding or stability of the protein, it will affect
and even disrupt all interactions of the mutated protein. On the other hand, if a mutation is
located at a specific protein-binding interface, it could affect only some of the interactions of
the mutated protein or "edges" in a particular network, which could have functional conse-
quences for such network (so called edgetic effect) [15]. Indeed, alterations on the edges of the
interactome are the underlying cause of many disorders [15–17]. Large-scale structural studies
show that pathological mutations are enriched on the domains that are involved in protein-
protein interactions [18] and confirm that many disease-related mutations are physically
located at protein-protein interfaces [17,19,20]. A different study found that OMIM nsSNPs
cause small changes in the binding energy of protein interactions [21]. The integration of avail-
able 3D structures of proteins complexes with the interaction network analysis can improve
our understanding of the functional mechanisms of disease-related mutations [22]. For exam-
ple, a study combining interaction network analysis, structural data and energetic calculations,
found that a significant percentage of the known pathological mutations in the RAS/MAPK
pathways affected the binding affinity of some of the interactions in such network [22–24],
which provided a general explanation for some of the differences in phenotype.
In addition to improving our knowledge of disease at molecular level, understanding the
role of pathological mutations in protein-protein interactions is also of paramount importance
for predicting purposes. The functional prediction of nsSNPs that cause amino acid changes in
proteins is difficult because they can modify the cellular behavior through different mecha-
nisms, for instance by affecting protein stability, function, or interactions with other proteins
and biomolecules [25], as we mentioned above. Thus, for a given mutation found in a patient
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screening or in population genomic analyses, it would be important to characterize their
potential involvement in protein interactions, in order to improve their annotation and/or
predict their pathological character by complementing general predictive methods like Poly-
Phen-2 [26,27], or SIFT [28].
Thus, in order to fully characterize the effect of a pathological mutation at molecular level
and have useful information for prediction purposes, it is important first to identify whether
the mutation is located at a protein-binding interface, and second to understand the effect on
the binding affinity of the affected interaction/s. However, the limited structural data on PPIs
make all the above mentioned studies incomplete. The number of protein-protein complexes
with their 3D structure deposited in the Protein Data Bank (PDB) [29] is very small. Weak or
transient complex structures are particularly difficult to determine by crystallography or
NMR, due to technical limitations. There is a growing gap between the number of protein
complexes with available experimental structure and the number of interactions that are being
discovered. So far the scientific community has available structural data for around half of the
non-redundant proteins in human, but only for less than 7% of the estimated human interac-
tome [30]. Computational methods, such as protein docking [31,32] or post-docking analysis
[33,34] are currently used to complement existing experimental efforts and could help to build
the human structural interactome [35]. However, the main problem for interactomics applica-
tion is that, for many cases, accurate prediction of a protein-protein structure by docking is
still very challenging. Fortunately, the identification of interface residues, based on sequence
conservation or physicochemical properties, is more accurate and can be applied at larger
scale. Of special importance is the identification of hotspots residues, which are the ones that
contribute the most to the binding energy [36]. We previously showed that it is possible to
identify interface hot-spots from docking calculations, without needing prior information of
the complex structure [37]. Here we have extended the original pyDockNIP method to predict
the location of disease-associated nsSNPs at protein-protein interfaces, when there is no avail-
able structure for the protein-protein complex. We have applied this approach to the patholog-
ical interaction networks of six diseases with low structural data on PPIs. Our method finds
51% of the known interface disease-associated nsSNPs with 62% precision, and predicts a
significant number of additional disease-associated nsSNPs (1.5 times the number of known
disease nsSNPs based only on the structures) that could be involved in protein-protein
interactions.
Results
Structural analysis of pathological mutations on protein interaction
networks
The general aim of this work is to show how docking-based computational approaches can
help characterizing disease-related mutations in PPIs at interactomic scale, where the majority
of protein-protein interfaces have no structural data. For this purpose, we focused our analysis
on the protein-protein interaction networks of six disease phenotypes for which there was
detailed structural information for most of the individual proteins within the network, but low
structural coverage of the protein-protein interfaces (see Methods). Table 1 shows the number
of proteins associated to each disease according to OMIM that have available structure or a
reliable homology-based model (see Methods), as well as the number of proteins and com-
plexes forming the first-layer interaction network and their structural coverage.
We first analyzed the distribution of nsSNPs within the protein interaction networks of the
six analyzed diseases (see Methods), considering only those protein-protein interactions that
had available structure (or a reliable homology model). This structural dataset was formed by
Docking-based characterization of missense mutations
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462 protein-protein complexes that had available structure (or a reliable homology-based
model), and involved 353 proteins with available structure (experimental or modelled). We
found that 258 of these proteins had at least one annotated nsSNP (Table 2). The entire set
comprised a total of 1,624 nsSNPs that could be structurally characterized using the complex
structures, of which 832 were related to a disease (not necessarily any of the originally analyzed
six diseases), 499 were classified as polymorphisms, and 293 were unclassified. Among the
structurally mapped disease nsSNPs, 48% are buried, 22% are located at a protein-protein
interface, and 30% are found at a non-interacting surface (Fig 1A). We can compare these
numbers with the values expected by chance for buried, interface and non-interface residues
(29%, 31% and 40%, respectively), as estimated from the residue composition of the studied
proteins (see Methods). Thus, the observed/expected (O/E) ratios for buried, interface and
non-interface disease nsSNPs are 1.68, 0.70 and 0.75, respectively. The disease nsSNPs are
located in buried positions clearly more often than expected by random, which has already
been observed in previous studies [17,19]. However, the O/E value for the interface disease
nsSNPs obtained here (0.70) is clearly below that reported in previous studies on a large inter-
action data set (0.96 [17]; an earlier studied found this value to be 1.20, but in that case inter-
face residues were defined exclusively based on distance criteria and could include some
buried residues [19]). More interesting is to analyze the preference of a disease nsSNP for
being at a protein-protein interface rather that at a non-interacting surface, computed as an
odds ratio (OR) (see Methods). Here, we found that disease nsSNPs had similar probability of
occurring at protein interfaces than at non-interacting surfaces (OR 0.94) (S1 Table). Again,
this value is lower than that previously reported on a large interaction dataset, in which they
found a clear preference of disease nsSNPs to be at interface regions rather than non-interact-
ing surfaces (OR 1.35 [17]). The lower preferences found here for the disease nsSNPs to be
located at protein-protein interfaces can be explained by the low structural coverage of the pro-
tein interactions in the six diseases studied here (which were indeed selected because they had
high structural coverage for the individual proteins but low structural coverage on the protein-
protein complexes). This shows that the lack of structural data on protein-protein complexes
might underestimate the role of many disease nsSNPs involved in protein interactions and can
lead to poor characterization of the effect of these mutations in the network topology.
Table 1. Structural coverage of the disease-related protein interaction networks analyzed in this work.
Phenotype OMIM code Associated proteinsa Protein interaction networks
Proteinsb Interactionsc
HIGM5 608106 2 (2, 0) 17 (6, 11) 21 (5, 0)
LHON 535000 6 (0, 6) 23 (11, 10) 34 (9, 1)
CRC 114500 10 (4, 6) 270 (142, 81) 691 (102, 43)
MCI 608446 11 (8, 3) 193 (102, 61) 582 (101, 57)
HIV-1 609423 25 (13, 12) 91 (63, 21) 142 (59, 13)
CMH 192600 7 (3, 4) 198 (84, 80) 531 (66, 43)
All six diseasesd 61 (30, 31) 729 (361, 249) 1934 (311, 151)
a Number of proteins associated with each disease according to the OMIM database, with available structure or a reliable homology-based model (see
Methods). In brackets, the number of proteins with available structure and those with homology-based model, separated by comma (#structures, #models).
b Number of proteins forming the 1st-layer interaction networks of the disease-associated proteins (see Methods). In brackets, number of proteins with
available structure or homology-based model, separated by comma.
c Number of interactions in the interaction networks of the proteins associated to each disease. In brackets, protein-protein complexes with available
structure or homology-based model, separated by comma.
d Global data for all the selected six diseases, after removing redundant data (union of the different data for the individual diseases).
https://doi.org/10.1371/journal.pone.0183643.t001
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Thus, it remains to be seen whether having more structural data on the protein interactions
for these six diseases analyzed here could improve the structural and functional characteriza-
tion of known disease-related nsSNPs. The following section will explore computational ways
to extend the structural characterization of protein interaction networks.
Prediction of interface residues by docking
The main goal of this work is to explore computational ways of characterizing pathological
mutations possibly involved in protein-protein interactions for which there is no available
structural data. We previously found that energy-based protein docking can be efficiently
applied to identify interface and hot-spot residues in protein-protein complexes [37]. Basically,
from the resulting docking poses, we obtained a normalized interface propensity (NIP) per res-
idue, which describes how often a given residue is involved in the 100 lowest-energy docking
interfaces (see Methods). This approach was implemented in the pyDockNIP module within
our docking protocol pyDock [33]. We have evaluated the predictive capabilities of this
method at different NIP cutoff values, on the protein-protein docking benchmark 4.0, and the
Table 2. Detailed analysis of the location of nsSNPs in the disease-related protein interaction networks, based on complex structures and mod-
elled interactions.
Structural data Docking-based models Structural data & docking-based models
Total number of proteins 353 583 603
Proteins with known nsSNP 258 411 424
Total residues
Number of residues 76168 189629 199846
Core residues 21710 53849 54936
Interface residues 23779 55031 68768
Non-interacting surface residues 30679 80749 76142
Hot-spot residues 5918 11839 16449
Hot-spot residues at interface 3673 11839 14459
Total nsSNPs
Number of nsSNPs 1624 2615 2786
Disease 832 1363 1438
Polymorphism 499 851 899
Unclassified 293 401 449
Non-interacting surface nsSNPs
Disease 250 384 343
Polymorphism 188 399 340
Unclassified 118 126 125
Core nsSNPs
Disease 399 609 629
Polymorphism 118 231 228
Unclassified 102 130 146
Interface nsSNPs
Disease 183 370 466
Polymorphism 193 221 331
Unclassified 73 145 178
Interface hot-spot nsSNPs
Disease 33 74 109
Polymorphism 46 35 76
Unclassified 17 47 61
https://doi.org/10.1371/journal.pone.0183643.t002
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results (Fig 2A) confirm that this method can predict interface residues with high precision
(65–70%), but very low sensitivity (less than 10%). This sensitivity level is too low for its appli-
cability at large protein interaction networks, given that the majority of pathological mutations
involved in protein interfaces would not be detected. In order to improve its applicability, we
have extended the predicted interface patches by including residues in the vicinity of the origi-
nally predicted ones (see Methods). This strategy showed a better trade-off between precision
and sensitivity, with improved sensitivity up to 28%, at the expense of precision (Fig 2A).
As an additional test, we applied the extended interface predictions to the structural interac-
tion networks of six selected diseases, as above mentioned, containing 462 protein-protein
interactions for which the complex structure is available or can be modelled based on a homol-
ogous template, which involved 353 proteins with available structure (or a reliable homology-
based model). Some of the proteins in this dataset had more than one binding partner, so we
considered as interface residues those that are involved in any of the possible interactions. As
a consequence, 44% of the surface protein residues were observed to be located at a protein-
protein interface (Table 2). Then computational docking was run on the separated complex
components of the 449 protein-protein complexes, being them either x-ray structures or
homology-based models, and the extended interface predictions were compared to the
real interface residues. The predictions yielded a precision of 64%, with a sensitivity of 50%
Fig 1. Distribution of nsSNPs in the protein interaction networks of six selected diseases. Distribution of nsSNPs (detailed for
disease, polymorphism and unclassified) in the protein interaction networks from the six selected diseases, as classified in core, interface
and surface non-interface, with expected distributions as calculated from residue composition, and odds ratios (OR) for the different residue
locations and types of nsSNPs, based on (A) structural data; (B) modelled interactions; and (C) combined structural data and modelled
interactions. Only significant OR values (P < 0.05) are shown.
https://doi.org/10.1371/journal.pone.0183643.g001
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(Fig 2B). This improvement in the predictive success rates with respect to the results in the
protein-protein docking benchmark might be due to the fact that many of the proteins in the
disease-associated interaction networks showed several binding partners, and thus the
observed proportion of interface residues in that set (44%) was larger than in the docking
benchmark (23%). To estimate the random accuracy, we randomly selected 44% of the surface
residues as random interface predictions (to keep the same proportion as in the real inter-
faces), and this approach showed 43% precision and 36% sensitivity for the prediction of
Fig 2. Prediction of interface residues and nsSNPs. (A) Prediction success (sensitivity and precision) of interface
residues using pyDockNIP (alone or extended with neighbor residues) on the proteins of the protein-protein docking
benchmark 4.0, according to NIP cutoff value. (B) Interface and nsSNPs predictions using the extended pyDockNIP
predictions on the proteins of the structural interaction networks from the six selected diseases. The nsSNPs predictions
are detailed for interface disease-related, polymorphism and unclassified nsSNPs.
https://doi.org/10.1371/journal.pone.0183643.g002
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interface residues in the structural interaction networks. As an additional test, we selected a
small set of 28 proteins that had only one known interacting partner in the structural interac-
tion networks (i.e. we disregarded proteins with multiple interactions), and we docked all
these proteins with randomly chosen proteins that were different from their known partners.
Using these random docking pairs, our extended interface predictions showed 46% precision,
and 23% sensitivity for the prediction of interface residues. This shows that the docking-based
interface predictions proposed in this work achieves predictive success rates well above ran-
dom, for which using the specific partner/s in docking is critical.
Docking-based interface prediction can help to improve nsSNP
characterization
We then tested the docking-based extended interface predictions on all the nsSNPs found in
the structural interaction networks of the six selected diseases. We applied this methodology to
the identification of interface nsSNPs, and the predictive success rates were similar to those of
the interface predictions (Fig 2B). As an additional test, we focused on the disease-related
nsSNPs within the same structural interaction networks. Thus, we applied our docking-based
method to the 832 disease-related nsSNPs in our structural dataset in order to predict whether
they were located at interfaces. When compared with the 183 disease-related nsSNPs that were
actually located at interfaces in our structural dataset, the predictions showed very similar
numbers in precision (62%) and sensitivity (51%) to those for the interface predictions (Fig
2B). When applied to other types of nsSNPs, the prediction success rates were also similar,
except for the "unclassified" nsSNPs, for which sensitivity is slightly lower (Fig 2B). In general,
the above results show that docking-based predictions can identify with reasonable precision
when a given nsSNP is located at a protein-protein interface, independently on whether such
nsSNP is associated to a disease or no. This provides a valuable resource to characterize
nsSNPs in cases with no structural information on the potential protein-protein interactions.
Identification of interface nsSNPs in complexes with no available
structure
The above described protein interaction networks for the six selected diseases contained 1,472
interactions for which there is no available structure. They involved as many as 3,323 nsSNPs
that could not be structurally mapped in such interactions. Some of these nsSNPs might have
been considered in the previous analysis of the structural interaction network dataset, simply
because they were involved in other complexes with available structure, but they still lacked
information for all the other interactions with no available structure. In 1,055 of these interac-
tions, the interacting subunits had available structure or could be easily modelled by homol-
ogy, which made them suitable for docking calculations. In total, there were 583 proteins with
structure or easily modelled by homology (Table 2). We ran docking simulations on these
interactions to predict interface residues, and then used this information to identify nsSNPs
located at protein-protein interfaces. Some of the interacting proteins have different PDB
structures corresponding to different parts of the protein, in which case we used all of these
structures independently in docking. For instance, in the interaction between the oncogene
RAF1 and the heat shock protein HSP90AA1, there are five different PDB structures associated
to RAF1, covering different zones of the protein, and two different PDB structures associated
to HSP90AA1. Such discontinuous structural coverage for these proteins makes that the
modeling of this interaction alone needs 10 independent docking simulations. As a conse-
quence, we run a total of 8,920 docking simulations, and as many of 2,615 nsSNPs could be
characterized in 1,055 modelled protein-protein complexes. Within these nsSNPs, we found
Docking-based characterization of missense mutations
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1,363 disease-related, 851 polymorphisms, and 401 unclassified. Among the docking-based
characterized disease nsSNPs, 45% were buried, 27% were located at a protein-protein inter-
face, and 28% at a non-interacting region (Fig 1B). According to the residue composition of
the studied proteins in the docking predictions, the values expected by chance for buried,
interface and non-interface nsSNPs are 28%, 29%, and 43%, respectively. Incidentally, these
interface/non-interface residue composition values in the docking predictions show that the
predicted interfaces in these interaction networks are similar in size to the real ones. This is an
additional advantage of the extended interface predictions over the original NIP-based
method, which provided much smaller interfaces. Thus, the O/E ratios for buried, interface
and non-interface disease nsSNPs are 1.57, 0.94 and 0.66, respectively. These numbers are vir-
tually the same as those found in previous studies on larger interaction sets (1.58, 0.96, and
0.71, respectively [17]). Based on the modelled interactions, disease nsSNPs have clear prefer-
ence for being at protein-protein interfaces as compared with non-interacting surfaces (OR
1.42), also in line with previous studies (OR 1.35 [17]). This shows that modeling interaction
networks by docking has the capability of extending the characterization of nsSNPs in cases
with no available structural data.
Integrated experimental and computational characterization of protein
interaction networks
Then, we combined the results of the structural dataset with the modelled interactions for the
protein interaction networks of the six selected diseases. In this way, we had structural or mod-
elled data for 1,517 protein-protein interactions, involving proteins that harbored a total of
2,786 nsSNPs. They contained 1,438 disease-related, 899 polymorphisms and 449 unclassified
nsSNPs. Among the characterized disease-related nsSNPs, 44% were buried, 32% were located
at interfaces, and 24% at non-interacting regions (Fig 1C). According to the residue composi-
tion of the structurally characterized and modelled proteins, the values expected by chance for
buried, interface and non-interface residues are 27%, 34%, and 38%, respectively. Thus, the O/
E ratios for buried, interface and non-interface disease nsSNPs are 1.59, 0.94 and 0.63, respec-
tively (similar to previous studies [17]). This indicates an even clearer preference of the disease
nsSNPs for being at interfaces rather than at non-interacting regions (OR 1.51), a preference
that could not be detected before using only structural data due to the limited number of avail-
able complex structures for these selected diseases. Indeed, based only on the available struc-
tural data, 183 disease nsSNPs were found at protein interfaces, while 250 were found at non-
interacting surfaces. When data from docking was included, as many as 112 of these 250
nsSNPs (45%) were actually found at protein-protein interfaces. This clearly shows that the
combination of experimental and computational information can help to improve the struc-
tural characterization of protein interaction networks and the identification of nsSNPs involved
in interactions, which could not be previously found due to the lack of structural data.
Interestingly, the disease-related nsSNPs that are estimated to be interacting hot-spots
according to the docking-based predictions (interface residues with NIP> 0.2) show an O/E
ratio of 1.05, and a clear preference over the non-interacting regions (OR 1.68), similar to that
previously reported for interface core disease nsSNPs vs. non-interacting regions (OR 1.72 [17]).
For the interaction networks of the six selected diseases, on top of the 183 disease-related
nsSNPs that could be structurally mapped at protein-protein interfaces, we found 283 addi-
tional disease-related nsSNPs that were predicted to be at an interface based on the docking
models. We should note that some of the nsSNPs residues predicted as interface from the
docking models could have been already defined as interface from the complex structures,
because they were involved in other interactions for which there was available structure, and
Docking-based characterization of missense mutations
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this is why last column in Table 2 is not simply the sum of the two previous columns. Consid-
ering all the available structural and docking-based data, we found a total of 109 interface dis-
ease-related nsSNPs that were also characterized as hot-spots, and which are likely to have a
significant edgetic effect (see Discussion).
Docking-based characterization of pathological mutations in the RAS/
MAPK pathway
We used our interface prediction method to extend the characterization of nsSNPs in other
protein interaction networks. A recent comprehensive study on pathological mutations
involved in cancer and RASopathies in proteins of the RAS/MAPK pathway showed that
around 20% of the structurally-mapped pathological mutations were predicted to have a direct
effect on protein-protein or domain-domain interfaces [24]. However, for over 30% of the
mutations that could be mapped at a protein structure, they could not find any structural or
energetic reason that might explain their pathological character. The majority of these muta-
tions were located at the protein surface, and the authors proposed that they might be involved
in protein interactions for which there is no sufficient structural data. Some of the mutations
could be located at a known protein-protein interface but perhaps do not have any impact on
the binding affinity [21], while they could actually affect other protein-protein interactions
with no available structural data [38,39]. Therefore, we aimed to complete the interface struc-
tural and energetics data of this protein interaction network with our computational approach,
to explore whether this can help characterizing some of these "unexplained" mutations. We
used the first-degree neighbors from Interactome3D server [30] to construct the network for
the 15 proteins analyzed in the mentioned study [24].
The complete interaction network involved a total of 236 proteins, 234 of them with avail-
able structure, and 482 protein-protein interactions (300 of them without structural informa-
tion). We performed 1,893 docking calculations on those protein interactions with no
available structure, in order to identify the interface and hot-spot residues. From the 208 path-
ological mutations that were unexplained in the mentioned study [24], we found 95 mutations
(in 59 residues of 11 proteins) that were predicted to be at a protein-protein interface based on
the docking calculations. That is, interface predictions based on docking calculations helped to
rationalize almost half of the unexplained mutations. Among them, we found 44 pathological
mutations (in 29 residues of 9 proteins) that were predicted to be located at a protein-protein
binding hot-spot residue (Fig 3). These nine proteins play a significant role in the RAS path-
way, and are found to interact with several other signaling proteins. Cross pathway connectiv-
ity among signaling proteins is a network property that is related to the robustness or fragility
of cell functions [39]. Therefore, mutations located at protein-protein interfaces in these
nine proteins could not only affect the RAS pathway but also other pathways. Fig 4 shows the
pathways involving proteins whose interaction is affected by the pathological mutations pre-
dicted to be located at a binding hot-spot. We found the most affected pathways are related to
the vascular system formation and activation of immune cells. The VEGF, PDGF, FGF and
interleukin signaling pathways are closely involved in cell proliferation, differentiation and
angiogenesis, all of them highly relevant in the development of cancer.
Discussion
Linking structural information to phenotypes
Structural characterization of nsSNPs and their involvement in protein-protein interfaces is a
starting point to understand complex diseases, for which databases like dSysMap [20] are
Docking-based characterization of missense mutations
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Fig 3. Structurally unexplained pathological mutations of the RAS/MAPK pathway that are predicted
to be involved at protein-protein interfaces. Proteins of the RAS/MAPK pathway are represented as
circles, showing pathological mutations that were not previously characterized due to the lack of structural
data, but that have been predicted here to be binding hot-spots when docking with specific protein partners
from this pathway (circles) or from the first-degree interaction network (in cyan squares). These docking
partners thus represent proteins whose interaction is predicted to be affected by the mutation to which they
are linked. Thus, all edges here correspond to interface predictions from docking.
https://doi.org/10.1371/journal.pone.0183643.g003
Fig 4. Pathways affected by pathological mutations in RAS/MAPK proteins predicted to be at binding
hot-spots. Proteins of the RAS/MAPK pathway are shown as colored circles, showing pathological mutations
that were not previously characterized due to the lack of structural data, but that have been predicted here to
be binding hot-spots for docking partner proteins involved in other pathways (linked to the corresponding
mutation). Pathways shown in red are those that could not have been found using only available structural
data.
https://doi.org/10.1371/journal.pone.0183643.g004
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valuable resources. However, a major problem is the limited structural data available for pro-
tein-protein complexes, and as a consequence, only a fraction of all possible nsSNPs can be
accurately located at the interfaces. In this work, we have used docking models to characterize
nsSNPs that are likely to be involved in protein-protein interactions. To test this approach, we
have selected six complex diseases in which their associated proteins are involved in protein-
protein interactions for which there is little structural data.
The first difficulty we encountered in this analysis was the availability of data. The task of
finding all the coding protein genes to construct the protein interaction network of a complex
disorder is not trivial, as there are different sources of data for nsSNPs (e.g. humsavar) and dis-
order genes (e.g. OMIM) that are not always fully consistent. Indeed, the gene map file used
here from OMIM had 3,012 disease phenotypes, while the version of humsavar used in this
work has 2,727 phenotypes with assigned nsSNPs. This means that there could be protein cod-
ing genes associated to a disease phenotype, which do not have any described nsSNP. An
example of this was the phenotype MCI (susceptibility to myocardial infarction) [MIM:
608446]. This phenotype is not considered in databases like dSySmap, because all coding pro-
tein genes that have been reportedly associated to the disease harbor mutations for other dis-
eases, and thus no nsSNPs can be found associated with this MIM code in humsavar (Table 1).
Therefore, a specific analysis of this phenotype using only the nsSNPs annotated in humsavar
is not realistic. When we analyzed the interaction network of the proteins associated to this
disease, including all nsSNPs associated to any other diseases, we found a strong preference
of these nsSNPs to be at an interface rather than in non-interacting regions (OR 1.52, P-
value< 0.005). The involvement of different nsSNPs causing other diseases in the protein-pro-
tein interfaces of this interaction network is indicative of a complex genotype-to-phenotype
relationship, which is probably masking the nsSNPs linked to this specific MCI phenotype.
Due to the limited availability of structural data, in phenotypes like the Leber hereditary
optic neuropathy (LHON) [MIM:535000], a rare mitochondrial disease, not a single LHON
nsSNP could be structurally mapped at a protein-protein interface, since there were no avail-
able structures for the protein-protein interactions associated to this disease (except for the
self-interactions, i.e. homocomplexes). Fortunately, we were able to model most of the protein
complexes of the LHON interaction network by means of computational docking. In this way,
we identified 4 LHON disease-related nsSNPs at protein-protein interfaces, involving 3 pro-
teins (MT_CO3, MT-ND1, and MT-ND5) that are part of the respiratory chain (Fig 5). One of
the proteins, MT_CO3 (UniProt P00414), is part of the complex IV assembly of the cyto-
chrome oxidase c, which is the terminal member of the respiratory chain of the mitochondria.
The other two affected proteins are components of the NADH-ubiquinone oxidoreductase
complex, which is key to the catalytic function of the respiratory chain. We could only analyze
part of the chain 1 (MT-ND1, UniProt P03886) and chain 5 (MT-ND5, UniProt P03915).
We could also characterize additional nsSNPs in the LHON interaction network related to
other diseases like Alzheimer and Breast-ovarian cancer (Fig 5). For instance, MT-ND1 and
MT-ND2 harbor additional nsSNPs at the interface that are also linked to other diseases, such
as Alzheimer’s disease (MIM 502500) and MELAS syndrome (MIM 540000). MT-ND1 and,
especially, MT-ND5 proteins are involved in the recognition of BCRT domains. The nsSNPs
that we found located in the interface might be very specific for this LHON disorder, probably
altering the recognition of such domains. We also found other elements of the respiratory
chain affected by nsSNPs at an interface zone, which were described to cause other mitochon-
drial related disorders. For example, the protein ELANE (P08246), a mitochondrial elastase, is
involved in two different diseases, cyclic hematopoiesis (CH; MIM 162800) and severe congen-
ital neutropenia 1 (SCN1; MIM 202700). Interestingly, the nsSNP I104N, which is known to
play a role in causing CH, is predicted here to be located at a protein-protein interface.
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Prediction of edgetic effects of SNPs affecting specific pathways
Crosstalk in cellular pathways provides the cell with a robust network of interactions to
respond to stimulus. The description of these pathway crosstalk events at molecular level and
the mutations that may affect them would open multiple applications in biomedicine, from
understanding the homeostatic response of a given drug in a particular population to discover-
ing new personalized scenarios for drug repurposing [40]. A recently reported interaction per-
turbation profiling of missense mutations across a broad spectrum of human disorders
suggests that around one third of disease mutations have edgetic effects [41]. The same study
shows that different mutations in the same gene may produce different interaction profiles
and, as a consequence, distinct disease phenotypes [41]. However, understanding the possible
edgetic effect of hundreds of thousands of mutations arising from genome-wide association
studies and gene sequencing efforts is being hampered by our currently limited structural
knowledge of protein interactions. The structural characterization of missense mutations by
combining complex structures and docking predictions, as shown in this work, can be essen-
tial to achieve this understanding at interactomic level. As an example, structural analysis of
the TNNC1 interaction network in MHC phenotype (Fig 6) shows that different nsSNPs could
affect the interaction with different proteins. Indeed, mutations affecting TNNT1 binding are
in different region than those affecting TNNI1 and TNNI2. Docking-based predictions can
help to understand the structural role of additional nsSNPs that are involved in interactions
for which there is no available structural data. For instance, based on the docking models,
CDK1 binding has been found to be affected by TNNC1 nsSNPs D145E, G159R and E134D;
UBE2C binding is found to be affected by E134D; and RBM15B binding is found to be affected
by G159R and E134D (Fig 6).
Fig 5. LHON interaction network with disease-related nsSNPs located at modeled protein-protein
interfaces. Proteins associated with LHON pathology (circles) and their modeled interactions (edges) with
other proteins of the network (squares), showing the disease nsSNPs (for LHON and other pathologies) that
are located at the modelled protein-protein interfaces. The homology-modeled structures for selected proteins
are shown in ribbon, with disease nsSNPs in CPK representation, and all residues colored according to their
NIP value (in red NIP > 0.2; in blue NIP < 0.0).
https://doi.org/10.1371/journal.pone.0183643.g005
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In the case of RASopathies, where several of the network nodes are important interaction
hubs, a given disease-associated nsSNP at the interface region might have an edgetic effect by
affecting certain specific pathways but not others. We found that many of the disease-related
nsSNPs that could not be explained in a previous study [24] were located at the docking
extended interfaces, thus affecting around 50 protein partners that were involved in 38 differ-
ent pathways. Moreover, some of these disease-related nsSNPs were located at hot-spot resi-
dues, which were found to affect 26 different pathways (Fig 4). As much as 25 of these
pathways are mediated by interaction partners of BRAF and HRAS. The remaining one, the
nicotinic acetylcholine receptor signaling pathway, was affected by a pathological mutation in
CBL. In total, there are 8 pathways affected by the mutations at the predicted hot-spots that
would have not been identified based only on the available structural data (Fig 4). According
to our hotspot prediction, the pathways that are involving a larger number of proteins whose
interaction was predicted to be affected by pathological mutations are the RAS pathway, VEGF
signaling pathway, T cell activation and angiogenesis. All of these pathways involve interaction
partners of both BRAF and HRAS proteins.
Conclusions and future perspectives
We have presented here a procedure to improve the characterization of genomic variants
involved in protein-protein interactions, especially in cases with low or limited structural
information on the binding complexes. The application of interface and hotspot predictions
based on docking simulations can extend the structural knowledge of protein-protein inter-
faces and estimate the role of nsSNPs regarding the interaction with other proteins. We have
applied this to selected protein interaction networks for disease in which little structural data
for the protein complexes were available. This approach can almost double the number of
Fig 6. Effect of nsSNPs in TNNC1 interaction network based on complex structures and modelled
interactions. Analysis of TNNC1 interaction network by combining structural data and docking models can
identify different nsSNPs that could affect the interaction with different proteins. Protein-protein interactions
with available structure are represented as red edges. Modelled interactions are represented as cyan edges.
Selected protein-protein complex structures are shown, with residue color coding for the predicted NIP values
as in Fig 5.
https://doi.org/10.1371/journal.pone.0183643.g006
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nsSNPs that can be characterized and identify edgetic effect of many nsSNPs that were previ-
ously unknown. In summary, this procedure overcome current limitations of complex struc-
tures and can help to understand the structural and functional role of genomic variants
involved in protein-protein interactions, and their edgetic effect on specific protein interaction
networks within a given disease. Future research will focus on improvement the structural
modeling of protein interfaces by novel scoring methodologies, integration with template-
based docking, or optimized flexibility treatment. The will help to annotate and interpret geno-
mic data from large-scale population studies, and to achieve a better understanding of disease
at molecular level.
Methods
Disease-associated proteins and interaction networks
Genes associated with different diseases were obtained from the OMIM database [2]. Thus,
2,394 distinct proteins (based on UniProt ID) were found to be associated to a total of 3,012
disease phenotypes (based on OMIM ID) (S2 Table). From this, pathological interaction net-
works were built by selecting the first layer interaction partners for proteins associated to each
disease using the Interactome3D server [30], which contains only protein-protein interactions
for which there is reliable evidence that they are binary. Only disease-associated proteins with
available structure (or reliable homology-based model in Interactome3D [30]) were used as
seeds to build the interaction networks, in order to be able to map known nsSNPs variants on
them (see below). Structural data (experimental or modeled) for the proteins and complexes in
each interaction network were also retrieved from Interactome3D [30]. When several struc-
tures or models were found for a given case, we selected the ones with the highest coverage
and/or sequence identity from the proteins.dat file of the database. In some cases, we found
different structures for the same protein (UniProt code), corresponding to different parts of
the protein, so they were independently used for the different analyses in this work.
Statistical analysis of nsSNPs on disease-associated protein interaction
networks
In this work, we selected six disease phenotypes for which there were detailed structural infor-
mation for most of the individual proteins within the network, but low structural coverage of
the protein-protein interfaces (Table 1): Hyper-IgM syndrome 5 (HIGM5); Leber hereditary
optic neuropathy (LHON); Colorectal cancer (CRC); Susceptibility to myocardial infarction
(MCI); Susceptibility to HIV type 1 (HIV-1); and CardioMyopathy Hypertrophic variants 1 to
15 (CMH). S3 Table shows the proteins associated to these six selected diseases (based on the
OMIM database). S4 Table shows the proteins contained in the first layer interaction networks
of the six selected diseases, and their structural coverage (based on Interactome3D). S5 Table
shows the complexes forming the first-layer interaction network of the six selected diseases,
and their structural coverage (based on Interactome3D).
The nsSNPs variants for each gene in the protein structural interaction networks associated
to the six selected disease phenotypes were obtained from the humsavar.txt file (release
2014_06 of June 11th, 2014; downloaded from www.uniprot.org) and mapped to the corre-
sponding protein structure (S6 Table). For this, the human sequences with all the variants
were downloaded in a FASTA format from the UniProt web page [42]. Then, the sequence
and numbering of the PDB files in our dataset were extracted and aligned with the correspond-
ing FASTA sequence when the numbering was incorrect or shifted. The nsSNPs were classi-
fied, according to the humsavar.txt file, as: i) disease-associated, when the mutation is known
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to cause a disorder; ii) polymorphism, when the mutation is believed to be a neutral mutation;
and iii) unclassified, when the mutation is detected in one or few patients, but showed low sta-
tistical significance due the limited size of the sample.
Residues in the protein structures were classified as core, interface and non-interacting sur-
face according to the available structural data on the known protein-protein complexes (S6
Table). Core residues were those with relative ASA < 0.1 (relative ASA is the ASA value for a
given residue over the ASA reference value of the corresponding residue type). Then, exposed
residues (relative ASA > 0.1) were classified as interface residues if any of their atoms are
found within 10 Å from another atom from a partner protein. The remaining residues are clas-
sified as non-interface surface. When multiple structures exist for a single protein, to avoid
ambiguous classifications for the same residue we used for classification the average of relative
ASA (rASA) for the residue in each of the structures. In a few cases, the same residue could be
defined as core based on the complex structures and as exposed based on the docking predic-
tions (in those interactions with no complex structure, see next section), or vice versa, depend-
ing on which structures are used in each case for the average rASA calculations.
The observed/expected (O/E) ratios for the distribution of nsSNPs in the above mentioned
protein regions (core, interface and non-interacting surface) were calculated as the observed
fraction of nsSNPs found in each protein region over the fraction of nsSNPs expected by
chance in each protein region. The latter was estimated from the fraction of total residues
found in each protein region in all analyzed proteins.
The preference of a nsSNP for being in a given protein region i rather that in a region j was
computed as an odds ratio (OR), as previously described [19]:
ORij ¼
Pi=ð1   PiÞ
Pj=ð1   PjÞ
ð1Þ
where Pi is the probability of observing a nsSNP of a given type in protein region i, and is com-
puted as:
Pi ¼
ni
Ni
ð2Þ
where ni is the number of nsSNPs of a given type observed in protein region i, and Ni is the
total number of residues in protein region i in all the analyzed proteins. The statistical signifi-
cance of the OR values were estimated by a two-tailed P-value, as previously described [19],
using the statistical packages in R (version 3.1.1).
Prediction of extended interface patches by pyDockNIP
We have developed a new version of the pyDockNIP method for predicting interface residues
in a given protein-protein complex, as follows. Docking simulations were run with FTDock
[43] to generate 10,000 rigid-body docking poses, which were rescored by pyDock [33]
energy-based function composed of van der Waals, electrostatics and solvation energy terms.
From the docking results, normalized interface propensity (NIP) values per residue were cal-
culated with the built-in pyDockNIP module [37]. Basically, for each residue, the averaged
buried surface (ABS) was calculated as the relative difference between its accessible surface
area (ASA) in the unbound structure and the average ASA of that residue in the 100 lowest-
energy docking poses. The ABS values were normalized in order to obtain the NIP value per
residue [37]. Residues with NIP value greater or equal to 0.2 were predicted to be interface
hot-spot residues. This was previously shown to provide a good compromise between preci-
sion and sensitivity, and yielded similar success rates to other predictive methods [37]. The
Docking-based characterization of missense mutations
PLOS ONE | https://doi.org/10.1371/journal.pone.0183643 August 25, 2017 16 / 20
novelty here is that the predicted interface patches were extended by including surface residues
(relative accessible surface area rASA> 0.1) within 10 Å distance from the predicted interface
hot-spot residues. This method was used to characterize nsSNPs as core, interface or non-
interacting surface in complexes with no structural data (S6 Table).
The protein-protein docking benchmark 4.0 [44] was used to test the performance of the
above described method to predict extended protein-protein interfaces. We processed all the
176 complexes in the benchmark with our docking-based interface prediction protocol, start-
ing from the structures of the unbound proteins. The predicted extended interface patches
were compared to the real interfaces, which were composed of those residues within 10 Å of
the partner molecule in the complex structure. Then sensitivity and precision of the method
were computed as follows.
SensitivityðSÞ ¼
TruePositives
TruePositivesþ FalseNegatives
ð3Þ
PrecisionðPÞ ¼
TruePositives
TruePostivesþ FalsePositives
ð4Þ
Identification of interface pathological mutations at RAS/MAPK cascade
We used our interface prediction method to extend a previous study [24] on 956 RASopathy
and cancer missense mutations found in 15 genes of the RAS/MAPK pathway: PTPN11, SOS1,
RASA1, NF1, KRAS, HRAS, NRAS, BRAF, RAF1, MAP2K2, MAP2K1, SPRED1, RIT1,
SHOC2 and CBL. For the determination of possible pathways affected by the nsSNPs at the
interface of the proteins, we used the GO annotation for the functional classification of genes
provided by PANTHER database [45].
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